Schüpke, Stefanie ; Neumann, Franz-Josef ; Menichelli, Maurizio ; Mayer, Katharina ; Bernlochner, Isabell ; Wöhrle, Jochen ; Richardt, Gert ; Liebetrau, Christoph ; Witzenbichler, Bernhard ; Antoniucci, David ; Akin, Ibrahim ; Bott-Flügel, Lorenz ; Fischer, Marcus ; Landmesser, Ulf ; Katus, Hugo A. ; Sibbing, Dirk ; Seyfarth, Melchior ; Janisch, Marion ; Boncompagni, Duino ; Hilz, Raphaela ; Rottbauer, Wolfgang ; Okrojek, Rainer ; Möllmann, Helge ; Hochholzer, Willibald ; Migliorini, Angela ; Cassese, Salvatore ; Mollo, Pasquale ; Xhepa, Erion 
; Kufner, Sebastian ; Strehle, Axel ; Leggewie, Stefan ; Allali, Abdelhakim ; Ndrepepa, Gjin ; Schühlen, Helmut ; Angiolillo, Dominick J. ; Hamm, Christian W. ; Hapfelmeier, Alexander ; Tölg, Ralph ; Trenk, Dietmar ; Schunkert, Heribert ; Laugwitz, Karl-Ludwig ; Kastrati, Adnan
; Kufner, Sebastian ; Strehle, Axel ; Leggewie, Stefan ; Allali, Abdelhakim ; Ndrepepa, Gjin ; Schühlen, Helmut ; Angiolillo, Dominick J. ; Hamm, Christian W. ; Hapfelmeier, Alexander ; Tölg, Ralph ; Trenk, Dietmar ; Schunkert, Heribert ; Laugwitz, Karl-Ludwig ; Kastrati, Adnan 
Zusammenfassung
Background The relative merits of ticagrelor as compared with prasugrel in patients with acute coronary syndromes for whom invasive evaluation is planned are uncertain. Methods In this multicenter, randomized, open-label trial, we randomly assigned patients who presented with acute coronary syndromes and for whom invasive evaluation was planned to receive either ticagrelor or prasugrel. The ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric